Third-dose BNT162b2 vaccine is highly efficient at increasing anti-rbd sars-cov-2 igg titers in allo-hct recipients

Canti, L.; Humblet-Baron, S.; Desombere, I.; Pannus, P.; Henry, A.; Servais, S.; Willems, E.; Arien, K. K.; Beguin, Y.; Goossens, M. E.; Marchant, A.; Baron, F.

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Third-dose BNT162b2 vaccine is highly efficient at increasing anti-rbd sars-cov-2 igg titers in allo-hct recipients

Canti, L.; Humblet-Baron, S.; Desombere, I.; Pannus, P.; Henry, A.; Servais, S.; Willems, E.; Arien, K. K.; Beguin, Y.; Goossens, M. E.; Marchant, A.; Baron, F..

Bone Marrow Transplantation ; 57(SUPPL 1):280-280, 2022.

Article in English | Web of Science | ID: covidwho-2112261

Search on Google

Print

XML

Collection: Databases of international organizations Database: Web of Science Topics: Vaccines Language: English Journal: Bone Marrow Transplantation Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Print

XML

Collection: Databases of international organizations Database: Web of Science Topics: Vaccines Language: English Journal: Bone Marrow Transplantation Year: 2022 Document Type: Article